Month: May 2022

When age is more than a number: undergraduate SCRMC lab member Samuel Neuman focuses on regenerative medicine as a way to impede diseases of degeneration and aging

By Bekah McBride Aging is part of the human experience, but not every experience is the same. Progressive neurodegenerative diseases such as Parkinson’s, Huntington’s, and Alzheimer’s disease present many challenges to patients and their families, and researchers like University of Wisconsin–Madison junior Samuel Neuman are using stem cells and regenerative medicine to find a solution. …

SCRMC Director Tim Kamp pens perspectives piece for Quarterly magazine

Nearly twenty-five years ago, University of Wisconsin-Madison researcher James Thomson described the first successful derivation of human embryonic stem cells (hESCs). These cells, which are pluripotent, meaning they can form any cell type and self-renewing, meaning they can grow indefinitely in culture, changed the way diseases are understood and treated. While the past two decades have included dramatic advances, there is still much to learn, and clinical trials are just beginning for a variety of degenerative diseases. Dr. Kamp outlines the opportunities, challenges, and the history of stem cell research in his column “Stem Cells and Regenerative Medicine: A long, but promising road” available on page 40 of the spring 2022 Quarterly magazine.